SCHEMBL1015090

SCHEMBL1015090

COC(=O)c1cc(Cl)ccc1NC(=O)C(=O)Nc1cccc(-c2ccoc2)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 6/20 0.79
CNR1 P21554 4/20 0.57
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
ATM Q13315 1/20 0.43
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NR4A2 P43354 1/20 0.42
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GRIK1 P39086 1/20 0.41
F10 P00742 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015149 0.88 SERPINE1 (1.00) SERPINE1CNR1MEN1KMT2AALDH1A1
SCHEMBL29492571 0.88 SERPINE1 (1.00) SERPINE1CNR1MEN1KMT2AALDH1A1
SCHEMBL1015662 0.87 SERPINE1 (0.64) SERPINE1CNR1MEN1KMT2AALDH1A1
SCHEMBL1012933 0.87 SERPINE1 (0.61) SERPINE1CNR1MEN1KMT2AALDH1A1
SCHEMBL1016838 0.85 SERPINE1 (0.81) SERPINE1CNR1ALDH1A1MAPTNPC1
SCHEMBL419057 0.84 SERPINE1 (0.78) SERPINE1CNR1ALDH1A1MAPTNPC1
SCHEMBL418556 0.82 SERPINE1 (0.61) SERPINE1CNR1MEN1KMT2AALDH1A1
SCHEMBL416816 0.81 SERPINE1 (0.53) SERPINE1CNR1MEN1KMT2AALDH1A1
SCHEMBL419000 0.80 SERPINE1 (0.60) SERPINE1CNR1ALDH1A1NPC1NR4A2
SCHEMBL419148 0.80 SERPINE1 (0.82) SERPINE1MEN1KMT2AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885CNR1 3950/4885MEN1 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.